| helicobacter pylori kx2 npgec | streptococcus gordonii | helicobacter pylori kx1 npgec | GeneSet Name |
|---|
| -0.00740 | -0.00750 | -0.00278 | NUYTTEN_NIPP1_TARGETS_DN |
| -0.00160 | -0.08889 | -0.00057 | TIEN_INTESTINE_PROBIOTICS_24HR_UP |
| -0.00736 | -0.06984 | -0.00673 | PUJANA_CHEK2_PCC_NETWORK |
| -0.00788 | -0.14542 | -0.00296 | CAIRO_HEPATOBLASTOMA_UP |
| -0.08710 | -0.02094 | -0.16118 | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN |
| -0.01837 | -0.02422 | -0.04935 | GALE_APL_WITH_FLT3_MUTATED_UP |
| -0.06326 | -0.03505 | -0.07573 | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN |
| -0.01335 | -0.01700 | -0.01083 | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 |
| -0.00946 | -0.00213 | -0.01154 | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
| -0.18789 | -0.03828 | -0.18396 | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP |
| -0.06040 | -0.12328 | -0.01530 | SEIDEN_MET_SIGNALING |
| -0.00991 | -0.12189 | -0.10410 | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP |
| -0.00017 | -0.07547 | -0.00038 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
| -0.05313 | -0.02100 | -0.01765 | MARTINEZ_RESPONSE_TO_TRABECTEDIN |
| -0.06351 | -0.00514 | -0.10257 | BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP |
| -0.03689 | -0.08001 | -0.02015 | LUI_THYROID_CANCER_PAX8_PPARG_UP |
| -0.10060 | -0.07524 | -0.07224 | MMS_MOUSE_LYMPH_HIGH_4HRS_UP |
| -0.00683 | -0.10799 | -0.00925 | MITSIADES_RESPONSE_TO_APLIDIN_DN |
| -0.10988 | -0.08289 | -0.05094 | BIOCARTA_NFAT_PATHWAY |
| -0.05775 | -0.00028 | -0.03537 | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP |
| -0.02043 | -0.07473 | -0.02015 | MILI_PSEUDOPODIA_CHEMOTAXIS_UP |
| -0.04648 | -0.16086 | -0.18865 | NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON |
| -0.05018 | -0.11858 | -0.06281 | DAZARD_RESPONSE_TO_UV_SCC_UP |
| -0.14395 | -0.14267 | -0.03153 | CHOI_ATL_CHRONIC_VS_ACUTE_DN |
| -0.02754 | -0.00856 | -0.01416 | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN |
| -0.00417 | -0.06444 | -0.00276 | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP |
| -0.11048 | -0.15389 | -0.06746 | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q |
| -0.03980 | -0.02793 | -0.02071 | ONKEN_UVEAL_MELANOMA_UP |
| -0.16449 | -0.18302 | -0.07886 | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN |
| -0.01985 | -0.00004 | -0.02887 | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP |
| -0.10000 | -0.00406 | -0.03532 | NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON |
| -0.04230 | -0.10813 | -0.00610 | KOBAYASHI_EGFR_SIGNALING_24HR_DN |
| -0.02116 | -0.02710 | -0.00563 | NCI_RETINOIC_ACID_PATHWAY |
| -0.08129 | -0.05514 | -0.04996 | BIOCARTA_TGFB_PATHWAY |
| -0.11221 | -0.14496 | -0.10314 | NCI_TRAIL_PATHWAY |
| -0.02703 | -0.01864 | -0.01394 | UDAYAKUMAR_MED1_TARGETS_UP |
| -0.10153 | -0.11759 | -0.07377 | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 |
| -0.03829 | -0.01148 | -0.09958 | WANG_LMO4_TARGETS_DN |
| -0.02938 | -0.19205 | -0.05272 | GUTIERREZ_MULTIPLE_MYELOMA_DN |
| -0.11939 | -0.01051 | -0.02540 | AMIT_EGF_RESPONSE_240_MCF10A |
| -0.15012 | -0.15515 | -0.08120 | NCI_MITOTIC_METAPHASE_ANAPHASE_TRANSITION |
| -0.10600 | -0.00010 | -0.08176 | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM |
| -0.04049 | -0.15607 | -0.03272 | LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN |
| -0.12049 | -0.00003 | -0.07984 | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN |
| -0.06681 | -0.19729 | -0.05431 | POTTI_CYTOXAN_SENSITIVITY |
| -0.04255 | -0.00049 | -0.05312 | SCHLOSSER_SERUM_RESPONSE_DN |
| -0.11699 | -0.05080 | -0.19719 | LIU_SOX4_TARGETS_UP |
| -0.03829 | -0.14305 | -0.01962 | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
| -0.06317 | -0.08449 | -0.07418 | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN |
| -0.02831 | -0.00002 | -0.02663 | GEORGES_TARGETS_OF_MIR192_AND_MIR215 |
| -0.13669 | -0.00139 | -0.15220 | AMIT_SERUM_RESPONSE_240_MCF10A |
| -0.06658 | -0.08931 | -0.07277 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR |
| -0.05003 | -0.06516 | -0.01944 | SASSON_RESPONSE_TO_FORSKOLIN_DN |
| -0.10129 | -0.08297 | -0.16861 | RODRIGUES_NTN1_TARGETS_UP |
| -0.09987 | -0.13006 | -0.03160 | NCI_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_ALPHA__PPARALPHA_ |
| -0.07873 | -0.00138 | -0.06471 | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP |
| -0.01849 | -0.15525 | -0.00381 | PUJANA_XPRSS_INT_NETWORK |
| -0.02836 | -0.00002 | -0.01531 | RAMALHO_STEMNESS_UP |
| -0.02705 | -0.12815 | -0.01003 | BENPORATH_CYCLING_GENES |
| -0.07313 | -0.00079 | -0.09658 | GENTILE_RESPONSE_CLUSTER_D3 |
| -0.07937 | -0.00030 | -0.04536 | GEORGES_CELL_CYCLE_MIR192_TARGETS |
| -0.07293 | -0.00077 | -0.14078 | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER |
| -0.15562 | -0.07365 | -0.10985 | LUI_THYROID_CANCER_CLUSTER_1 |
| -0.06743 | -0.16015 | -0.04994 | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP |
| -0.13217 | -0.03731 | -0.15268 | HENDRICKS_SMARCA4_TARGETS_DN |
| -0.02703 | -0.05307 | -0.00300 | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP |
| -0.00219 | -0.16606 | -0.01125 | STEIN_ESRRA_TARGETS_DN |
| -0.01293 | -0.05111 | -0.00761 | ELVIDGE_HYPOXIA_DN |
| -0.04610 | -0.07031 | -0.02619 | WANG_LMO4_TARGETS_UP |
| -0.06708 | -0.14242 | -0.13456 | SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP |
| -0.03740 | -0.09728 | -0.02755 | PYEON_HPV_POSITIVE_TUMORS_DN |
| -0.04272 | -0.00093 | -0.01156 | ZHANG_BREAST_CANCER_PROGENITORS_UP |
| -0.08119 | -0.17121 | -0.00721 | KEGG_ADHERENS_JUNCTION |
| -0.04431 | -0.00399 | -0.01060 | TOOKER_GEMCITABINE_RESISTANCE_DN |
| -0.01971 | -0.00063 | -0.01763 | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN |
| -0.08840 | -0.03756 | -0.00650 | BECKER_TAMOXIFEN_RESISTANCE_DN |
| -0.01177 | -0.06595 | -0.01818 | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN |
| -0.05491 | -0.03416 | -0.02322 | SASSON_RESPONSE_TO_GONADOTROPHINS_DN |
| -0.00955 | -0.00058 | -0.00728 | BIDUS_METASTASIS_UP |
| -0.11023 | -0.00996 | -0.06541 | PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN |
| -0.04417 | -0.00019 | -0.13547 | WANG_CLIM2_TARGETS_DN |
| -0.01931 | -0.08460 | -0.03039 | KEGG_THYROID_CANCER |
| -0.02710 | -0.08414 | -0.03537 | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN |
| -0.14307 | -0.19193 | -0.12162 | CORUM_SEC6/8_EXOCYST_COMPLEX |
| -0.09110 | -0.17534 | -0.11269 | BIOCARTA_RARRXR_PATHWAY |
| -0.00192 | -0.03908 | -0.00330 | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP |
| -0.08575 | -0.00160 | -0.06399 | OSMAN_BLADDER_CANCER_UP |
| -0.00899 | -0.12780 | -0.01547 | GENTILE_UV_RESPONSE_CLUSTER_D8 |
| -0.05104 | -0.01096 | -0.05065 | WEI_MYCN_TARGETS_WITH_E_BOX |
| -0.10216 | -0.00006 | -0.04602 | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN |
| -0.09725 | -0.00367 | -0.06401 | JI_RESPONSE_TO_FSH_DN |
| -0.03111 | -0.08498 | -0.02271 | KIM_WT1_TARGETS_DN |
| -0.06834 | -0.00018 | -0.07623 | WENDT_COHESIN_TARGETS_UP |
| -0.07936 | -0.18997 | -0.02715 | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN |
| -0.02447 | -0.16568 | -0.00905 | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP |
| -0.16363 | -0.19777 | -0.03941 | NETPATH_IL_5_PATHWAY_DOWN |
| -0.10959 | -0.00127 | -0.17846 | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN |
| -0.00596 | -0.15515 | -0.00277 | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP |
| -0.04213 | -0.00450 | -0.01328 | TOOKER_RESPONSE_TO_BEXAROTENE_UP |
| -0.03870 | -0.00215 | -0.06590 | DODD_NASOPHARYNGEAL_CARCINOMA_DN |
| -0.02017 | -0.03026 | -0.02084 | TIEN_INTESTINE_PROBIOTICS_6HR_DN |